MARINUS PHARMACEUTICALS INC·4

Jan 19, 5:19 PM ET

MARINUS PHARMACEUTICALS INC 4

4 · MARINUS PHARMACEUTICALS INC · Filed Jan 19, 2017

Insider Transaction Report

Form 4
Period: 2017-01-17
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
  • Award

    Restricted stock

    2017-01-17+60,60060,600 total
    Common Stock (60,600 underlying)
  • Award

    Stock option (right to buy)

    2017-01-17+141,400141,400 total
    Exercise: $1.21Exp: 2027-01-17Common Stock (141,400 underlying)
Footnotes (4)
  • [F1]Options to purchase shares of common stock vest in 36 equal monthly installments commencing 1/31/2017.
  • [F2]Each share of restricted stock represents the right to receive, at settlement, one share of common stock.
  • [F3]Shares of restricted stock vest in three equal annual installments of 20,200 on 1/17/18, 1/17/19 and 1/17/20.
  • [F4]Not applicable.

Documents

1 file
  • 4
    a4.xmlPrimary

    4